Celgene Corporation (CELG) |
|
108.24 0.11 (0.1%)
|
11-20 16:00 |
|
Open: |
108.01 |
Pre. Close: |
108.13 |
|
High:
|
108.59 |
Low:
|
107.27 |
|
Volume:
|
191,230,586 |
Market Cap:
|
77036M |
|
|
|
|
Celgene Corp is a biotech company that discovers, develops, and commercializes therapies designed to treat cancer and immune-inflammatory related diseases. Its registered brands are Abraxane, Istodax, Otezla, Pomalyst, Revlimid, Thalomid, Vidaza. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
108.37 - 109.047 |
109.047 - 109.525 |
|
Low:
|
106.592 - 107.459 |
107.459 - 108.07 |
|
Close:
|
107.111 - 108.37 |
108.37 - 109.257 |
|
Technical analysis |
as of: 2019-12-13 4:29:38 PM |
|
Overall:
|
  |
| Stoxline posted a SELL today, upgraded from strong sell. Downward movement continues, but could change at any time. |
| Target: |
Six months: 129.30 One year: 151.02 |
| Support: |
Support1: 104.40 Support2: 100.50 |
| Resistance: |
Resistance1: 110.70 Resistance2: 129.30 |
| Pivot: |
108.91 |
| Moving Average: |
MA(5): 109.60  MA(20): 108.01
MA(100): 98.50 MA(250): |
| MACD: |
MACD(12,26): 1.98 Signal(9): 2.24 |
| Stochastic oscillator: |
%K(14,3): 68.58 %D(3): 81.10 |
| RSI: |
RSI(14): 61.15 |
| 52-week: |
High: 110.70 Low: 58.59 Change(%): 48.7 |
| Average Vol(K): |
3-Month: 395739 10-Days: 588374 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.CELG has closed above bottom band by 33.1%. Bollinger Bands are 25% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Wed, 12 Feb 2020 12:00:00 +0000
Better Buy: bluebird bio vs. Gilead Sciences
Tue, 21 Jan 2020 20:46:00 +0000
Merck's Keytruda Could Face Direct Competition from New Chinese Drug
Mon, 06 Jan 2020 04:26:40 +0000
Here's Why Bristol-Myers Squibb Jumped 12.7% in December
Mon, 16 Dec 2019 14:55:41 +0000
Bristol-Myers Placed A Big Bet On Celgene’s Pipeline. Will It Pay Off For Investors?
Tue, 19 Nov 2019 14:02:27 +0000
Technology Sector Update for 11/19/2019: JKS, NOW, CELG, BMY, BILI, MSFT, AAPL, IBM, CSCO, GOOG
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: Nasdaq Global Select |
| Sector: Healthcare |
| Industry: Drug Manufacturers - Major |
| Shares Out. (M) |
|
| Shares Float (M) |
|
|
% Held by Insiders
|
|
|
% Held by Institutions
|
|
|
Shares Short (K)
|
|
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
|
|
Book Value (p.s.)
|
|
|
PEG Ratio
|
|
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
|
|
Return on Equity (ttm)
|
|
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
|
|
Levered Free Cash Flow (M)
|
|
Stock Valuations |
|
P/E
|
|
|
P/E Growth Ratio
|
|
|
P/BV
|
|
|
P/S
|
-10000000000.00 |
|
P/CF
|
|
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
